ANAB
ANAPTYSBIO, INC
NASDAQ · Healthcare · Biotechnology · US
$48.28
−0.74%Margins
Gross margin
133.1%
EBITDA margin
38.7%
EBIT margin
56.4%
Net margin
82.4%
FCF margin
7.6%
1849.1%
Return on equity
61.7%
Return on assets
47.8%
Return on invested capital
0.73x
Asset turnover
$18.1M
Cash from operations
$5.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026